Jonathan Rubin - SVP, Chief Medical Officer at Supernus Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP, Chief Medical Officer
Stock Symbol
SUPN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jonathan Rubin since 9/17/2023

Holdings reported by Jonathan Rubin for Supernus Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 4.64K $135K $29.06 Feb 23, 2024 Direct
Restricted Stock Unit 3.75K $109K $29.06 Feb 23, 2024 Direct Common Stock
Employee Stock Option (Right to Buy) 25K Feb 22, 2024 Direct Common Stock
Performance Share Unit 0 $27.66 Dec 22, 2023 Direct Common Stock

Transactions reported by Jonathan Rubin for Supernus Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.